MARAVAI LIFESCIENCES HLDGS-A (MRVI) Institutional Ownership Changes & 13F Activity
MARAVAI LIFESCIENCES HLDGS-A (MRVI) institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC 13F filings (Q1 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions among tracked filers. Notable filers include First Eagle U.S. Value and Renaissance Technologies LLC.
| Portfolio quarter | Name | Type | Quantity | Remaining | Reported stock balance |
|---|---|---|---|---|---|
| Q1 2026 | First Eagle U.S. Value | Buy | 725,000 | 2,524,336 | $7,143,871 |
| Q1 2026 | Renaissance Technologies LLC | Buy | 39,600 | 4,264,689 | $12,069,070 |
| Q4 2025 | First Eagle U.S. Value | Buy | 1,348,405 | 1,799,336 | $5,847,842 |
| Q4 2025 | Renaissance Technologies LLC | Sell | -93,000 | 4,225,089 | $13,731,539 |
| Q3 2025 | First Eagle U.S. Value | Buy | 450,931 | 450,931 | $1,294,172 |
| Q3 2025 | Renaissance Technologies LLC | Buy | 131,900 | 4,318,089 | $12,392,915 |
| Q2 2025 | Renaissance Technologies LLC | Buy | 75,500 | 4,186,189 | $10,088,715 |
| Q1 2025 | Renaissance Technologies LLC | Buy | 138,500 | 4,110,689 | $9,084,623 |
| Q4 2024 | Renaissance Technologies LLC | Sell | -166,286 | 3,972,189 | $21,648,430 |
| Q3 2024 | Renaissance Technologies LLC | Buy | 257,034 | 4,138,475 | $34,390,727 |
| Q2 2024 | Renaissance Technologies LLC | Buy | 668,552 | 3,881,441 | $27,791,118 |
| Q1 2024 | Renaissance Technologies LLC | Buy | 327,200 | 3,212,889 | $27,856 |
| Q4 2023 | Renaissance Technologies LLC | Buy | 226,000 | 2,885,689 | $18,901 |
| Q3 2023 | Renaissance Technologies LLC | Buy | 218,514 | 2,659,689 | $26,597 |
| Q2 2023 | Renaissance Technologies LLC | Sell | -751,325 | 2,441,175 | $30,344 |
| Q1 2023 | Renaissance Technologies LLC | Sell | -134,448 | 3,192,500 | $44,727 |
| Q4 2022 | Renaissance Technologies LLC | Buy | 1,804,248 | 3,326,948 | $47,609 |
| Q3 2022 | Renaissance Technologies LLC | Sell | -352,300 | 1,522,700 | $38,875 |
| Q2 2022 | Renaissance Technologies LLC | Buy | 961,800 | 1,875,000 | $53,269 |
| Q1 2022 | Renaissance Technologies LLC | Buy | 368,400 | 913,200 | $32,209 |
| Q4 2021 | Renaissance Technologies LLC | Sell | -405,281 | 544,800 | $22,827 |
| Q3 2021 | Renaissance Technologies LLC | Buy | 305,281 | 950,081 | $46,630 |
| Q2 2021 | Renaissance Technologies LLC | Buy | 644,800 | 644,800 | $26,908 |
Frequently asked questions about MRVI activity
Which institutional owners are buying MRVI?
Institutional owners buying MRVI include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in MRVI activity?
"Buy" means an investor increased their reported position in MRVI compared to the prior reporting period. This reflects growing exposure to MARAVAI LIFESCIENCES HLDGS-A (MRVI) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in MRVI increasing?
Institutional interest in MRVI can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related MRVI insights
- MRVI Overview
- MRVI Institutions
- MRVI Institutional Ownership
- MRVI Top Shareholders
- MRVI Institutional Buying
- MRVI Institutional Selling
- MRVI Ownership Changes
- MRVI Insiders
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Owners in Q1 2026
- Most Sold Healthcare Stocks By Institutional Owners in Q1 2026
- Top Institutional Investor Stock Rankings